Erythrocyte deformability and its variation in diabetes mellitus
- PMID: 17249336
Erythrocyte deformability and its variation in diabetes mellitus
Abstract
Erythrocyte deformability improves blood flow in the microvessels and in large arteries at high shear rate. The major determinants of RBC deformability include cell geometry, cell shape and internal viscosity (i.e., mean cell hemoglobin concentration and components of the erythrocyte membrane). The deformability is measured by several techniques but filtration of erythrocytes through micro-pore membranes and ektacytometry are two sensitive techniques to detect changes in erythrocytes under varied experimental and diseased conditions. Diabetes mellitus (DM) is a metabolic disorder, characterized by varying or persistent hyperglycemia, which induces several changes in the erythrocyte membrane and its cytoplasm, leading to alteration in the deformability. A decreasing trend of deformability in these patients is observed. The shape descriptor form factor, as determined by processing of erythrocyte images, increases with the increase of blood glucose levels and shows a pattern similar to filtration time of erythrocyte suspensions through cellulose membranes. Fluidity of the membrane as measured in erythrocytes of these patients is decreased. With prolonged diabetic conditions the deformability of erythrocytes is further decreased, which may complicate the flow of these cells in microvessels.
Similar articles
-
Influence of hypercholesterolemia on deformability and shape parameters of erythrocytes in hyperglycemic subjects.Clin Hemorheol Microcirc. 2009;41(3):169-77. doi: 10.3233/CH-2009-1165. Clin Hemorheol Microcirc. 2009. PMID: 19276514
-
Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes.Clin Hemorheol Microcirc. 2004;31(4):273-80. Clin Hemorheol Microcirc. 2004. PMID: 15567897
-
Changes in erythrocyte aggregation and deformability in diabetes mellitus: a brief review.Indian J Exp Biol. 2009 Jan;47(1):7-15. Indian J Exp Biol. 2009. PMID: 19317346 Review.
-
Red blood cell deformability in diabetes mellitus: effect of phytomenadione.Int J Clin Pharmacol Ther Toxicol. 1993 Jan;31(1):1-5. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8444511
-
Red cell fluidity in hypertension.Clin Hemorheol Microcirc. 1999;21(3-4):179-81. Clin Hemorheol Microcirc. 1999. PMID: 10711740 Review.
Cited by
-
Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles.J Transl Autoimmun. 2022 Aug 7;5:100161. doi: 10.1016/j.jtauto.2022.100161. eCollection 2022. J Transl Autoimmun. 2022. PMID: 36039310 Free PMC article. Review.
-
The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study.Redox Rep. 2016 Jul;21(4):190-5. doi: 10.1179/1351000215Y.0000000032. Epub 2016 Feb 5. Redox Rep. 2016. PMID: 26207797 Free PMC article. Clinical Trial.
-
Erythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathy.PLoS One. 2014 Sep 4;9(9):e106912. doi: 10.1371/journal.pone.0106912. eCollection 2014. PLoS One. 2014. PMID: 25188352 Free PMC article.
-
Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19.Front Physiol. 2022 Jun 15;13:899629. doi: 10.3389/fphys.2022.899629. eCollection 2022. Front Physiol. 2022. PMID: 35784888 Free PMC article. Review.
-
Molecular hydrogen exposure improves functional state of red blood cells in the early postoperative period: a randomized clinical study.Med Gas Res. 2023 Apr-Jun;13(2):59-66. doi: 10.4103/2045-9912.356473. Med Gas Res. 2023. PMID: 36204784 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical